A Randomized, Double Blind , Placebo Controlled Trial to Compare the Effect of Tiotropium [Spiriva] Inhalation Capsules on Exercise Tolerance in Patients With COPD [chronic obstructive pulmonary disease] Participating in 8 Weeks of Pulmonary Rehabilitation

Trial Profile

A Randomized, Double Blind , Placebo Controlled Trial to Compare the Effect of Tiotropium [Spiriva] Inhalation Capsules on Exercise Tolerance in Patients With COPD [chronic obstructive pulmonary disease] Participating in 8 Weeks of Pulmonary Rehabilitation

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Oct 2013

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Dec 2007 Status changed from in progress to completed.
    • 10 Aug 2006 Status change
    • 30 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top